ICG and Goldman back Synerlab €160m refi
The unitranche package opens a capex line and acquisition line for the pharmaceutical company, which is expected to complete two purchases in the next couple of months.
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group .Issues with signing in? Click here
Don't have an account? Register now
The unitranche package opens a capex line and acquisition line for the pharmaceutical company, which is expected to complete two purchases in the next couple of months.
Nearly there!
A verification email is on its way to you. Please check your spam or junk folder just in case.
If you do not receive this within five minutes, please try to sign in again. If the problem persists, please email: subscriptions@pei.group.Copyright PEI Media
Not for publication, email or dissemination